Reuters logo
BRIEF-Guerbet to phase out Hexabrix and Optimark sales globally
July 10, 2017 / 5:11 AM / 2 months ago

BRIEF-Guerbet to phase out Hexabrix and Optimark sales globally

July 10 (Reuters) - GUERBET SA

* REG-GUERBET ANNOUNCES PLANS TO STREAMLINE

ITS CONTRAST MEDIA PORTFOLIO

* WILL PHASE OUT SALES THROUGHOUT WORLD OF TWO PRODUCTS: HEXABRIX® (MEGLUMINE AND SODIUM IOXAGLATE) AND OPTIMARK® (GADOVERSETAMIDE).

* ‍SALES OF OPTIMARK® WILL END FIRST JULY 26, 2017 IN EUROPEAN UNION COUNTRIES​

* ‍OPTIMARK® PHASE OUT WILL BE PROGRESSIVELY IMPLEMENTED IN OTHER GEOGRAPHIC AREAS UNTIL END OF 2019​

* ‍HEXABRIX® SALES IN EUROPE, ASIA AND LATIN AMERICA WILL PROGRESSIVELY CEASE, BY END OF 2019 AT LATEST​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below